Reports

• 2 doses of a Health Canada approved vaccine, or
• 3 doses of a Health Canada approved vaccine if you are immunocompromised.

Individuals at high risk for severe COVID-19 illness are recommended to get a booster dose 3 months after their last dose or COVID-19 infection to ensure the best possible protection during the respiratory season.

 This includes those who are:

• Aged 65 or older
• Residents of long-term care, retirement home, or other congregate care setting
• Aged 12 or older and moderately to severely immunocompromised or with an underlying medical condition
• Health care workers
• Pregnant
• Adult First Nations, Inuit, or Métis individuals or household members
• Adults in racialized and/or marginalized community disproportionately affected by COVID-19

Individuals that are not at high risk of severe outcomes should get their booster dose 6 months after their last COVID-19 vaccine dose or last COVID-19 infection.

 You can check to see when you're recommended to receive a booster dose using the Province's online tool.   

Individuals 5 years-of-age and older, infected with COVID-19 prior to their completion -or initiation of primary vaccine series are recommended to receive the next dose of vaccine 8 weeks after symptom onset or positive test.

Individuals 18 years of age and older, infected with COVID-19 after their primary series but before their booster dose, are recommended to receive their booster dose 3 months after symptom onset or positive test.

Individuals 12-17 year-of-age, infected with COVID-19 after their primary series but before their booster dose, are recommended to receive their booster dose 3 months after symptom onset or positive test, provided it's been at least 6 months after completing the primary series.

Individuals 5+ years-of-age who are not considered moderately to severely immunocompromised and with no previous history of multisystem inflammatory syndrome (MIS-C) in children can receive their first or second vaccine 8 weeks after symptom onset or positive test.

Individuals 5+ years-of-age who are moderately to severely immunocompromised and with no previous history of MIS-C can receive their first or second vaccine dose 4 to 8 weeks after symptoms onset or positive test.

Individuals 5+ years-of-age with a previous history of MIS-C (regardless of immunocompromised status) can receive their first or second vaccine dose when clinical recovery has been achieved or greater than 90 days since the onset of MIS-C, whichever is longer.

The recommended waiting times between the COVID-19 infection and vaccination are intended to minimize the risk of transmission of COVID-19 at an immunization clinic, enable monitoring for COVID-19 vaccine adverse events and increase immune response to vaccine. However, with informed consent individuals may opt to receive their first, second or a booster dose after symptoms of COVID-19 have resolved and they are no longer infectious.